Apyx Medical Corp (NASDAQ:APYX)’s stock price traded up 6.8% during mid-day trading on Tuesday . The company traded as high as $3.58 and last traded at $3.46, 198,110 shares traded hands during mid-day trading. An increase of 111% from the average session volume of 93,700 shares. The stock had previously closed at $3.24.
A number of research analysts recently issued reports on the stock. ValuEngine raised shares of Apyx Medical from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, March 3rd. Zacks Investment Research cut shares of Apyx Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. BidaskClub raised shares of Apyx Medical from a “sell” rating to a “hold” rating in a research note on Wednesday, February 12th. Finally, Piper Sandler decreased their price objective on shares of Apyx Medical from to in a research note on Tuesday, March 17th. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Apyx Medical presently has a consensus rating of “Buy” and a consensus price target of $8.55.
The business’s 50 day simple moving average is $6.26 and its two-hundred day simple moving average is $7.14. The stock has a market cap of $110.71 million, a P/E ratio of -6.55 and a beta of 0.46. The company has a quick ratio of 7.93, a current ratio of 8.73 and a debt-to-equity ratio of 0.01.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Cowen AND Company LLC bought a new stake in shares of Apyx Medical in the fourth quarter worth $1,996,000. Goldman Sachs Group Inc. grew its stake in shares of Apyx Medical by 1,148.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 212,439 shares of the company’s stock worth $1,797,000 after purchasing an additional 195,417 shares during the last quarter. Lighthouse Financial Advisors Inc. bought a new stake in shares of Apyx Medical in the fourth quarter worth $1,465,000. State Street Corp grew its stake in shares of Apyx Medical by 34.2% in the third quarter. State Street Corp now owns 557,677 shares of the company’s stock worth $3,775,000 after purchasing an additional 142,098 shares during the last quarter. Finally, Calamos Advisors LLC bought a new stake in shares of Apyx Medical in the fourth quarter worth $1,164,000. 53.45% of the stock is currently owned by hedge funds and other institutional investors.
About Apyx Medical (NASDAQ:APYX)
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue.
Featured Story: How interest rates affect municipal bond prices
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.